Evidence map›Paper›PMID 33128011›Full record

ArticleScientific reports2020

The HIF1α/JMY pathway promotes glioblastoma stem-like cell invasiveness after irradiation.

Laurent R Gauthier, Mahasen Saati, Hayet Bensalah-Pigeon, Karim Ben M'Barek, Oscar Gitton-Quent, Romane Bertrand, Didier Busso, Marc-André Mouthon, Ada Collura, Marie-Pierre Junier and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Laurent R GauthierUniversité de Paris and Université Paris-Saclay, Inserm, LRP/iRCM/IBFJ CEA, UMR Stabilité Génétique Cellules Souches et Radiations, 18 route du panorama, 92265, Fontenay-aux-Roses, France. laurent-r.gauthier@cea.fr.
Mahasen SaatiUniversité de Paris and Université Paris-Saclay, Inserm, LRP/iRCM/IBFJ CEA, UMR Stabilité Génétique Cellules Souches et Radiations, 18 route du panorama, 92265, Fontenay-aux-Roses, France.
Hayet Bensalah-PigeonUniversité de Paris and Université Paris-Saclay, Inserm, LRP/iRCM/IBFJ CEA, UMR Stabilité Génétique Cellules Souches et Radiations, 18 route du panorama, 92265, Fontenay-aux-Roses, France.
Karim Ben M'BarekUniversité de Paris and Université Paris-Saclay, Inserm, LRP/iRCM/IBFJ CEA, UMR Stabilité Génétique Cellules Souches et Radiations, 18 route du panorama, 92265, Fontenay-aux-Roses, France.ORCID http://orcid.org/0000-0002-2556-0325
Oscar Gitton-QuentUniversité de Paris and Université Paris-Saclay, Inserm, LRP/iRCM/IBFJ CEA, UMR Stabilité Génétique Cellules Souches et Radiations, 18 route du panorama, 92265, Fontenay-aux-Roses, France.
Romane BertrandSorbonne Université, UPMC Univ Paris 06, INSERM, UMRS 938, Equipe Instabilité des Microsatellites et Cancer, Centre de Recherche Saint Antoine, 75012, Paris, France.
Didier BussoUniversité de Paris and Université Paris-Saclay, Inserm, LRP/iRCM/IBFJ CEA, UMR Stabilité Génétique Cellules Souches et Radiations, 18 route du panorama, 92265, Fontenay-aux-Roses, France.
Marc-André MouthonUniversité de Paris and Université Paris-Saclay, Inserm, LRP/iRCM/IBFJ CEA, UMR Stabilité Génétique Cellules Souches et Radiations, 18 route du panorama, 92265, Fontenay-aux-Roses, France.ORCID http://orcid.org/0000-0003-2633-9179
Ada ColluraSorbonne Université, UPMC Univ Paris 06, INSERM, UMRS 938, Equipe Instabilité des Microsatellites et Cancer, Centre de Recherche Saint Antoine, 75012, Paris, France.ORCID http://orcid.org/0000-0003-0496-1768
Marie-Pierre JunierCNRS UMR8246, Inserm U1130, Neuroscience Paris Seine-IBPS, UPMC, Sorbonne Universités, Paris, France.
Hervé ChneiweissCNRS UMR8246, Inserm U1130, Neuroscience Paris Seine-IBPS, UPMC, Sorbonne Universités, Paris, France.ORCID http://orcid.org/0000-0001-7675-5061
José R PinedaUniversité de Paris and Université Paris-Saclay, Inserm, LRP/iRCM/IBFJ CEA, UMR Stabilité Génétique Cellules Souches et Radiations, 18 route du panorama, 92265, Fontenay-aux-Roses, France.ORCID http://orcid.org/0000-0002-0900-7466
François D BoussinUniversité de Paris and Université Paris-Saclay, Inserm, LRP/iRCM/IBFJ CEA, UMR Stabilité Génétique Cellules Souches et Radiations, 18 route du panorama, 92265, Fontenay-aux-Roses, France. francois.boussin@cea.fr.
Inserm · FRCentre National de la Recherche Scientifique · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human glioblastoma (GBM) is the most common primary malignant brain tumor. A minor subpopulation of cancer cells, known as glioma stem-like cells (GSCs), are thought to play a major role in tumor relapse due to their stem cell-like properties, their high resistance to conventional treatments and their high invasion capacity. We show that ionizing radiation specifically enhances the motility and invasiveness of human GSCs through the stabilization and nuclear accumulation of the hypoxia-inducible factor 1α (HIF1α), which in turn transcriptionally activates the Junction-mediating and regulatory protein (JMY). Finally, JMY accumulates in the cytoplasm where it stimulates GSC migration via its actin nucleation-promoting activity. Targeting JMY could thus open the way to the development of new therapeutic strategies to improve the efficacy of radiotherapy and prevent glioma recurrence.

Indexed as

Cell Line, TumorCell MovementCell NucleusCytoplasmGlioblastomaGliomaHumansHypoxia-Inducible Factor 1, alpha SubunitNuclear ProteinsRadiation, IonizingSignal TransductionTrans-ActivatorsHypoxia-Inducible Factor 1, alpha SubunitJMY protein, humanNuclear ProteinsTrans-Activators

Identifiers

PMID33128011
PMCPMC7603339
OpenAlexW3095276446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.